H. B. Fuller (NYSE:FUL – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 4.600-4.900 for the period, compared to the consensus estimate of 4.750. The company issued revenue guidance of -.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on FUL. Vertical Research raised H. B. Fuller from a “hold” rating to a “strong-buy” rating in a research report on Friday, March 27th. Royal Bank Of Canada set a $58.00 price target on shares of H. B. Fuller in a report on Wednesday, May 27th. JPMorgan Chase & Co. upgraded shares of H. B. Fuller from an “underweight” rating to a “neutral” rating and set a $58.00 price objective for the company in a research note on Wednesday, May 27th. Citigroup lifted their target price on shares of H. B. Fuller from $67.00 to $70.00 and gave the company a “buy” rating in a research report on Monday, March 30th. Finally, Wall Street Zen raised shares of H. B. Fuller from a “hold” rating to a “buy” rating in a research note on Sunday, March 29th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $66.40.
Get Our Latest Stock Report on FUL
H. B. Fuller Stock Performance
H. B. Fuller (NYSE:FUL – Get Free Report) last released its quarterly earnings results on Wednesday, June 24th. The specialty chemicals company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.37 by $0.04. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%.The firm had revenue of $950.27 million during the quarter, compared to analysts’ expectations of $924.83 million. During the same period last year, the firm posted $1.18 EPS. The business’s revenue was up 5.8% on a year-over-year basis. H. B. Fuller has set its FY 2026 guidance at 4.600-4.900 EPS. As a group, sell-side analysts anticipate that H. B. Fuller will post 4.78 EPS for the current fiscal year.
H. B. Fuller Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, May 14th. Stockholders of record on Thursday, April 30th were paid a $0.245 dividend. This represents a $0.98 dividend on an annualized basis and a dividend yield of 1.5%. This is a boost from H. B. Fuller’s previous quarterly dividend of $0.23. The ex-dividend date was Thursday, April 30th. H. B. Fuller’s dividend payout ratio is 32.34%.
Insider Buying and Selling at H. B. Fuller
In other H. B. Fuller news, CEO Celeste Beeks Mastin purchased 5,170 shares of the business’s stock in a transaction that occurred on Tuesday, April 7th. The stock was acquired at an average cost of $57.08 per share, with a total value of $295,103.60. Following the completion of the acquisition, the chief executive officer directly owned 8,670 shares of the company’s stock, valued at $494,883.60. This represents a 147.71% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.83% of the company’s stock.
H. B. Fuller News Summary
Here are the key news stories impacting H. B. Fuller this week:
- Positive Sentiment: H. B. Fuller reported second-quarter earnings of $1.41 per share, beating analyst estimates, while revenue of $950.3 million also topped forecasts and rose 5.8% year over year. H.B. Fuller Reports Second Quarter 2026 Results
- Positive Sentiment: The company raised its FY 2026 EPS guidance to 4.60-4.90, signaling confidence in continued earnings growth, though the midpoint is only slightly above consensus expectations. H.B. Fuller Reports Second Quarter 2026 Results
- Positive Sentiment: H. B. Fuller announced a recommended cash offer to acquire Advanced Medical Solutions Group for about £659 million, a move that strengthens its strategy in medical adhesives and broadens its growth profile. H.B. Fuller Announces Offer to Acquire Advanced Medical Solutions
- Neutral Sentiment: Additional coverage noted that the acquisition values Advanced Medical Solutions at about $942 million including debt, underscoring the size of the transaction but not adding new operating details for H. B. Fuller. H.B. Fuller to buy UK’s Advanced Medical Solutions for $942 million
- Neutral Sentiment: Another item highlighted executive share awards at Advanced Medical Solutions ahead of the takeover; this is more of a corporate housekeeping item than a direct driver of H. B. Fuller’s stock. AMS Grants Executive LTIP Awards Ahead of H.B. Fuller Takeover
- Negative Sentiment: H. B. Fuller’s updated FY 2026 EPS guidance range was slightly below the consensus estimate at the midpoint, which may temper some of the enthusiasm from the earnings beat. H.B. Fuller Reports Second Quarter 2026 Results
Hedge Funds Weigh In On H. B. Fuller
A number of institutional investors have recently modified their holdings of the stock. Aster Capital Management DIFC Ltd acquired a new stake in shares of H. B. Fuller in the fourth quarter valued at approximately $46,000. Brown Brothers Harriman & Co. bought a new position in H. B. Fuller in the 3rd quarter valued at $56,000. Advisory Services Network LLC acquired a new stake in shares of H. B. Fuller in the 3rd quarter valued at $58,000. EverSource Wealth Advisors LLC increased its stake in shares of H. B. Fuller by 129.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,218 shares of the specialty chemicals company’s stock valued at $73,000 after buying an additional 688 shares during the period. Finally, Danske Bank A S acquired a new stake in shares of H. B. Fuller in the 3rd quarter valued at $77,000. 95.93% of the stock is owned by institutional investors.
H. B. Fuller Company Profile
H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.
Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.
Featured Articles
- Five stocks we like better than H. B. Fuller
- Washington’s Quantum Push Puts IBM and IonQ on the Throne
- FedEx’s Earnings Drop May Be Missing the Bigger Freight Story
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
Receive News & Ratings for H. B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.
